J9144 Daratumumab, hyaluronidase
J-Codes
Also known as: daratumumab SC, Darzalex SC
Intravenous injection of daratumumab with hyaluronidase-fihj, a monoclonal antibody targeting CD38 with subcutaneous hyaluronidase for subcutaneous delivery.
Clinical Context
Subcutaneous formulation of daratumumab for multiple myeloma treatment, allowing faster subcutaneous administration.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.